市場調查報告書
商品編碼
1433408
全球牙科注射器市場 2023-2030Global Dental Syringes Market 2023-2030 |
預計在預測期內(2023-2030年),全球牙科注射器市場將以 5.3%的CAGR成長。牙周病患者對牙科注射器的需求激增、口腔健康狀況的盛行率不斷上升以及人們對口腔健康的認知不斷增強,推動了該市場的發展。根據世界衛生組織(WHO)統計,2020年全球唇癌和口腔癌發病率估計為377,713 例新發病例和177,757 例死亡病例。口腔癌在男性,尤其是老年人中更為常見和嚴重,與女性相比,男性的致命性更高,而且口腔癌因社會經濟環境而異。此外,用於良好口腔健康的技術先進產品不斷推出,加速了牙科注射器的採用。2023年 2月,Swallow Dental Supplies Ltd 推出了 bluem(R)預填充口腔凝膠注射器。這些易於操作的注射器每個含有 3 毫升 bluem(R)口服凝膠,目的是使應用過程比以往更容易。快速有效地治療和治癒患者的口腔健康問題,無需浪費一滴 bluem(R)口腔凝膠。
全球牙科注射器市場依產品和最終用戶細分。根據產品,市場分為可重複使用注射器和一次性注射器。此外,根據最終用途,市場細分為醫院、門診設施以及研究和製造。在最終用戶中,門診設施子細分市場預計將佔據相當大的市場佔有率,因為其交通方便,提供靈活的時間安排選項,對生活方式忙碌、尋求快速有效治療的個人有吸引力。
其中,可重複使用注射器細分市場預計將在全球牙科注射器市場中佔據相當大的佔有率。此細分市場的成長歸因於牙科手術和治療數量的增加,蛀牙、牙周病和口腔感染等牙科疾病的流行,刺激了對牙科注射器的需求。可重複使用的牙科注射器是各種牙科手術中局部麻醉、沖洗根管和其他應用的重要工具。根據美國疾病管制與預防中心(CDC)的資料,在美國,30 歲及以上的成年人中有 47.2%患有某種形式的牙周病。牙周病隨著年齡的成長而增加,65歲以上成年人中70.1%患有牙周病。
全球牙科注射器市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本、韓國和亞洲其他地區),以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於人們對牙齒衛生的意識不斷增強、人口老化以及高可支配收入推動歐洲牙科注射器市場的發展,預計歐洲將在全球市場中佔據顯著佔有率。
在所有地區中,亞太地區預計在預測期內將以相當大的CAGR成長。支持該區域市場成長的主要因素包括擴大採用先鋒技術,該地區醫療旅遊業的成長,口腔健康問題的盛行率增加以及口腔衛生意識的提高。2022年7月,第四次全國口腔健康調查顯示,中國成年人口腔健康問題普遍存在:牙齒完整的人僅佔13.8%,牙齒缺損的人佔84.4%,無牙頜的人佔1.8%。嚴重的牙齒缺失會給人們帶來沉重的疾病負擔。因此,產品開發投資的增加和口腔疾病的直接支出見證了牙科注射器市場的顯著成長。根據世界衛生組織的資料,美國在口腔健康方面的支出最高,為 1,340 億美元,其次是中國,為 610 億美元;兩者合計佔全球所有直接成本的 51%。
服務於牙科注射器市場的主要公司包括 3M Co.、A. Titan Instrument Inc.、DENTSPLY SIRONA Inc.、Integra LifeSciences Corp. 等。市場參與者透過各種策略(包括併購、夥伴關係、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2022年 2月,IMI(International Medical Industries, Inc.)發布了適用於 ENFit(R)和口服注射器的新型 Prep-Lock 防拆封蓋,並採用了無線射頻辨識(RFID)技術。
Global Dental Syringes Market Size, Share & Trends Analysis Report by Product (Reusable Syringes and Disposable Syringes), and by End-Use (Hospitals, Outpatient Facilities, and Research & Manufacturing), Forecast Period (2024-2031)
The global dental syringes market is anticipated to grow at a CAGR of 5.3% during the forecast period (2023-2030). The market is driven by the surging demand for dental syringes among individuals suffering from periodontal disorders, the rising prevalence of oral health conditions and growing awareness among the population for oral health. According to the World Health Organization (WHO), the global incidence of lip and oral cavity cancers is estimated to be 377,713 new cases and 177,757 fatalities in 2020. Oral cancer is more common and severe in men and especially elderly people, more deadly in men compared to women and it varies strongly by socio-economic circumstances. In addition, the rising technological advanced product launches for good oral health accelerating the adoption of dental syringes. In February 2023, Swallow Dental Supplies Ltd launched the bluem® Pre-Filled Oral Gel Syringes. These easy-to-handle syringes each contain 3 ml of bluem® Oral Gel and are designed to make the application process easier than ever before. Treat and heal your patients' oral health problems quickly and effectively without wasting a drop of bluem® Oral Gel.
The global dental syringes market is segmented on the product, and end-user. Based on the product, the market is sub-segmented into reusable syringes and disposable syringes. Further, based on the end-use, the market is sub-segmented into hospitals, outpatient facilities, and research & manufacturing. Among the end-user, the outpatient facilities sub-segment is anticipated to hold a considerable share of the market, owing to the easily accessible, offer flexible scheduling options, appealing to individuals with busy lifestyles who are seeking quick and effective treatments.
Among the products, the reusable syringes sub-segment is expected to hold a considerable share of the global dental syringes market. The segmental growth is attributed to the increasing number of dental procedures and treatments, prevalence of dental diseases, such as cavities, periodontal diseases, and oral infections, fuel the demand for dental syringes. Reusable dental syringes are essential tools in various dental procedures for delivering local anesthesia, irrigating canals, and other applications. According to the Centers for Disease Control and Prevention (CDC), in the US, 47.2% of adults aged 30 years and older have some form of periodontal disease. Periodontal disease increases with age, 70.1% of adults 65 years and older have periodontal disease.
The global dental syringes market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the increasing awareness about dental hygiene among population, growing aging population, and the high disposable income are driving the dental syringes market in the Europe.
Among all regions, Asia-Pacific is anticipated to grow at a considerable CAGR over the forecast period. The primary factor supporting the regional market growth includes the growing adoption of pioneering technologies, rising medical tourism in this region, increasing prevalence of oral health problems and rising awareness about oral hygiene. In July 2022, the 4th Chinese National Oral Health Survey showed that oral health problems were common in Chinese adults: only 13.8% had complete dentition, 84.4% had dentition defects, and 1.8% were edentulous. Severe tooth loss causes a high disease burden on the population. Consequently, rising investments in product development and direct expenditure for oral diseases has been witnessing significant growth of the dental syringes market. According to the WHO, the single highest total amount of $134 billion spent on oral health in the US, followed by China with $61 billion; both combined represent a 51% share of all direct costs around the globe.
The major companies serving the dental syringes market include 3M Co., A. Titan Instrument Inc., DENTSPLY SIRONA Inc., Integra LifeSciences Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2022, IMI (International Medical Industries, Inc.) released the new Prep-Lock Tamper Evident Cap for ENFit® and Oral Syringes with incorporated Radio Frequency Identification (RFID) technology.